CTRI/2024/07/070266尚未招募Unknown
The expression of HER2 low in gastric and gastroesophageal junction adenocarcinoma - NI
G B Pant institute of post graduate medical education and research0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Histopathological diagnosis of gastric or gastroesophageal junction adenocarcinoma
排除标准
- •Patients on neoadjuvant therapy, recurrent gastric/gastroesophageal junction adenocarcinoma and inadequate biopsy material.
研究者
相似试验
Unknown
1 期
Study of Ramucirumab, Trastuzumab and Paclitaxel in Patients With HER2-positive Recurrent/Metastatic Gastric Cancer (HER-RAM Study)Recurrent/Metastatic Gastric CancerNCT04888663Yonsei University50
尚未招募
不适用
To study HER-2/neu over expression in gall bladder cancersCTRI/2022/10/046831MGUMST
已完成
不适用
Research on HER2 expression in metastatic colorectal cancerColorectal cancerJPRN-UMIN000018786Japan Clinical Cancer Research Organization100
已完成
不适用
A screening study of HER2 expression for biliary tract cancerbiliary tract cancerJPRN-UMIN000036697ational Cancer Center300
Unknown
不适用
The Clinical Study of Assessing HER-2 Expression in Gastric Cancer With Extra Tumor Tissue Paraffin Blocks Using ImmunohistochemistryGastric Cancer Surgical Specimens,18-80 Years Old, at Least Two Tumor Tissue BlocksNCT02843412Shanghai Zhongshan Hospital2,000